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Purpose: The quality assurance (QA) procedures in particle therapy centers with active beam scanning 
make extensive use of films, which do not provide immediate results. The purpose of this work is to verify 
whether the 2D MatriXX detector by IBA Dosimetry has enough sensitivity to replace films in some of the 
measurements. 
Methods: MatriXX is a commercial detector composed of 32×32 parallel plate ionization chambers 
designed for pre-treatment dose verification in conventional radiation therapy. The detector and 
GAFCHROMIC® films were exposed simultaneously to a 131.44 MeV proton and a 221.45 MeV/u carbon-ion 
therapeutic beam at the CNAO therapy center of Pavia – Italy, and the results were analyzed and 
compared. 
Results: The sensitivity MatriXX on the beam position, beam width and field flatness was investigated. For 
the first two quantities, a method for correcting systematic uncertainties, dependent on the beam size, was 
developed allowing to achieve a position resolution equal to 230 µm for carbon ions and less than 100 µm 
for protons. The beam size and the field flatness measured using MatriXX were compared with the same 
quantities measured with the irradiated film, showing a good agreement.  
Conclusions: The results indicate that a 2D detector such as MatriXX can be used to measure many 
parameters of a scanned ion beam quickly and precisely and suggest that the QA would benefit from a new 
protocol where the MatriXX detector is added to the existing systems. 
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Introduction 
In radiation oncology, periodic verification of dosimetric data and radiation beam quality are required as 
part of quality assurance (QA) programs.1, 2 The correct use of radiations for therapeutic purposes is 
ensured by focusing on the detection of any possible abnormal behavior which may lead to deviations from 
the prescribed dose larger than tolerances. Several detectors are used for the dosimetry of both 
conventional and charged particle beams. Among these are ionization chambers, radiographic films, diodes, 
and radiochromic films. Ionization chambers are the reference instrumentations for absolute dose 
calibration either in standard radiotherapy, which uses photon beams, either in charged particle therapy 
(CPT), which uses ion beams.3 Film and diode measurements are also widely used with ion beams, although 
as the beam energy varies with depth, care must be taken to account for energy-dependent effects3 
especially if accurate quantitative measurements are required. 
The most advanced clinical implementations of CPT are the modulated scanning techniques, for which 
thousands of pencil beams are aimed in a rapid 3D sequence of spots conformed to the tumor. The 
complexity of the technique has generated the need for a new class of QA systems that permit rapid and 
precise two-dimensional (2D) and possibly three-dimensional (3D) measurements.  Most of the systems in 
use are based on single or arrays of ionization chambers and on films, which are certainly precise but suffer 
for lengthy procedures. Nichiporov et al.4 examined the usefulness of multichannel detectors, while in 
many other studies5-9, film dosimetry has been proposed to verify dose distributions and perform QA in 
proton therapy. Film dosimetry, shown to be highly precise, does not give immediate results because the 
procedures required for preparing, scanning, calibration, and off-line analysis are time-consuming. More 
recently, Y. Hara et al.10 published a paper on application of radiochromic films in the heavy-ion beam QA 
which has been performed at HIMAC. In this paper they have verified the QA measurements using the EBT2 
film by comparing the measurements with a reference ionization chamber and a fluorescent screen. It is 
shown that the results obtained with EBT2 were in good agreement with those obtained with the reference 
detector. This result confirms that the film can be used as a part of QA procedures for therapeutic scanned 
carbon-ion beams. 
Since several years, detectors made of 2D-arrays of ionization chambers are commercially available, 
examples being the OCTAVIUS Detector 729 XDR (PTW Freiburg, Germany) and the MatriXX (IBA Dosimetry, 
Schwarzenbruck, Germany). They are mainly designed for intensity-modulated radiotherapy (IMRT) QA, 
and in fact several investigators11-13 have assessed their adequacy for QA in conventional radiotherapy with 
photons, electrons, and in IMRT. On the other hand, currently no specific instrument is commercially 
available for use in CPT.14, 15 
Recently MatriXX has been shown to be an appropriate online device for machine QA checks of passive 
scattering14 and spot scanning16, 17 proton treatment facilities. At the University of Texas MD Anderson 
Cancer Center, the device has been proven to be accurate and fast for measuring the absolute dose, 
relative output factor, dose rate, flatness, and symmetry of the proton beams. Comparing the profiles, 
obtained using MatriXX, to films and to a 0.6 cc Farmer chamber in water, an excellent agreement, within 
1%, has been reported. Furthermore at the Center of MD Anderson the feasibility of using MatriXX for 
quick and accurate verification of patient-specific proton-dose distribution has been examined.15 
In the present study we have determined the performances of the 2D MatriXX detector for a set of 
measurements typically performed for QA of carbon ion beams. For completeness and comparison we have 
also studied the detector with proton beams. This study is preliminary to the design of a new QA procedure 
in CPT in which some of the operations are taken over by MatriXX measures. The work has been performed 
at CNAO (Centro Nazionale Adroterapia Oncologica, Pavia, Italy),18 where the QA procedure is presently 
well established and based on Gafchromic films and a water phantom with a ionization chamber.19 
Materials and Methods 
 At CNAO hadrontherapy center a synchrotron based on the PIMMS (Proton-Ion Medical Machine Study) 
design20 is used to deliver both proton and carbon ion beams. Patient treatments started with protons in 
September 2011 and with carbon ions in November 2012.  
A cycle of 4 to 5 s duration is the unit of operation of the accelerator and it is composed by the beam 
acceleration followed by the charged particles extraction, called spill. The duration of the spill is typically 1 s 
but can be extended up to two seconds if needed. During the inter-spill time, the machine is prepared for 
the next cycle by setting the beam elements for the desired beam. In addition to the selection of the beam 
species, beam particle’s energy, beam flux and beam transverse size can be selected among predefined 
values.  
The beam energy can be selected within a set of values between 120 MeV/u and 400 MeV/u for carbon 
ions and between 60 and 250 MeV for protons, corresponding to steps of particle range in water of 
approximately 1 mm, up to a maximum range of 27 cm. The accelerator can provide a maximum of 4×108 
C+6 or 1010 protons per spill, leading to a maximum beam current on the patient of 0.38 nA and 1.6 nA 
respectively. Lower currents can be achieved either by increasing the spill duration or by reducing the 
particles injected in the accelerator using injection grids. Two nominal beam transverse sizes are available 
for carbon ions, corresponding to 6 and 10 mm full width at half maximum (FWHM), while for protons a 
single FWHM of 10 mm is used.21 For this work, the carbon beam FWHM of 6 mm was selected in order to 
test the MatriXX detector with the most demanding beam conditions. 
Typically, in the transverse plane the beam is scanned through a grid with a pitch, projected on a plane 
perpendicular to the beam and located at the isocenter, of 2 mm for carbon ions and 3 mm for protons, 
with an accuracy of ±0.1 mm.18 The beam position and step size is controlled with two scanning magnets 
acting separately along horizontal (X) and vertical (Y) directions. By adjusting the currents in the magnets, 
the beam is deflected with the required precision.  All these design parameters fulfill the clinical requests. 
MatriXX22 is a commercial two-dimensional matrix of ionization chambers designed for pre-treatment 
verification of 2D dose distribution and for routine QA of photon and electron beams in conventional 
radiotherapy and IMRT. The device includes 1020 cells resulting from a 32×32 matrix with four missing 
chambers at the corners. Each detector cell is a parallel plate vented cylindrical ionization chamber with a 
size of 4.5(Ø)×5(h) mm2 and 0.08 cc sensitive volume, separated from the adjacent cells by 7.619 mm 
center-to-center distance. The active area is about 24.4×24.4 cm2. The charge produced by the ionizing 
tracks crossing the sensitive volume, proportional to the dose, is measured and digitized by a charge to 
digital count converter.23 Each count unit corresponds to 200 fC and the total number of counts is 
proportional to the dose deposited in each cell. At any given time all the counters can be latched by storing 
the contents in registers, thus providing a snapshot of the charges collected by the 1020 pixels. The data 
are then transferred to a PC via a standard Ethernet interface. The read out cycle for all the pixels may take 
a time as short as 500 µs. The performances of MatriXX in conventional radiotherapy have been discussed 
in several papers.11-13, 23, 25 
The OmniPro-I’mRT® software program (IBA, Be27) was used to control, calibrate and acquire data with the 
MatriXX detector. Before the measurements, a procedure recommended by the manufacturer was 
followed which includes the hardware/software setup, a warm-up and a pre-irradiation of the detector. 
Ambient temperature and pressure were entered into the acquisition program to correct for air-density 
variation in the ion chambers. To equalize the gains of all the 1020 channels, the detector was irradiated 
with a broad uniform field. The gains were then stored in the MatriXX software, and applied to all 
subsequent measurements. 
The program OmniPro-I’mRT® gives the possibility of acquiring consecutive snapshots at fixed time 
intervals, selected by the user, with MatriXX. For each snapshot any of the 1020 ionization chamber 
readings provide the absolute charge delivered in the corresponding time interval in terms of number of 
counts.  
A single spot was irradiated in each spill. The entire beam cycle was monitored with MatriXX having set-up 
the data acquisition in order to acquire snapshots at time intervals of 500 ms. Given a spill length of 
approximately 1 s, the spill in general was split over three snapshots and the beam cycle (4 s) over 9 
snapshots.  
For each snapshot, the 1020 data were recorded and logged in a file. The final analysis was implemented 
using the NI LabVIEW26 package. For most of the analyses, all snapshots related to a single spot were added 
off-line to have a single set of data for one irradiated spot. 
The center of gravity coordinates (𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐,𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐) of the spots were calculated using the formulae reported in 
the following: 
𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐 = ∑𝑆𝑆𝑖𝑖𝑖𝑖 × 𝑋𝑋𝑖𝑖,𝑖𝑖∑ 𝑆𝑆𝑖𝑖𝑖𝑖  ,    𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐 = ∑𝑆𝑆𝑖𝑖𝑖𝑖 × 𝑌𝑌𝑖𝑖,𝑖𝑖∑ 𝑆𝑆𝑖𝑖𝑖𝑖                  (1) 
where 𝑆𝑆𝑖𝑖𝑖𝑖 is the number of counts recorded in chamber (𝑖𝑖, 𝑗𝑗) and summed over the snapshots acquired 
when the corresponding spot was irradiated. (𝑋𝑋𝑖𝑖,𝑖𝑖,𝑌𝑌𝑖𝑖,𝑖𝑖) is the coordinates of the center of chamber (𝑖𝑖, 𝑗𝑗), 
and sums run over all the MatriXX chambers. 
The FWHM of the projections along 𝑋𝑋 and 𝑌𝑌 is interpreted as the beam width along 𝑋𝑋 and 𝑌𝑌 respectively, 
and was evaluated with the following relations: 
𝑋𝑋𝐹𝐹𝑊𝑊𝐻𝐻𝐻𝐻 = 2.355 × �∑𝑆𝑆𝑖𝑖𝑖𝑖(𝑋𝑋𝑖𝑖,𝑖𝑖 − 𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐)2∑ 𝑆𝑆𝑖𝑖𝑖𝑖  ,    𝑌𝑌𝐹𝐹𝑊𝑊𝐻𝐻𝐻𝐻 =  2.355 × �∑𝑆𝑆𝑖𝑖𝑖𝑖(𝑌𝑌𝑖𝑖,𝑖𝑖 − 𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐)2∑𝑆𝑆𝑖𝑖𝑖𝑖                  (2) 
where the symbols have the same meaning as in Eq. 1.  
Snapshots taken during the inter-spills, when no particles are extracted from the accelerator, were used to 
measure the electronics background level. We remark that the background level was found to be very small 
(< 1 ‰ of the maximum signal) and in this analysis has been neglected. 
Due to the geometry of MatriXX, which has an active area not fully covered, only parts of the irradiation 
fields can be probed and the reconstructed beam position and width can be affected by systematic errors. 
To estimate such errors, related to the pitch and size of the MatriXX chambers and beam width, a simple 
Monte Carlo was developed. Referring to Figure 1, given the position (𝑋𝑋,𝑌𝑌) of the beam central axis with 
respect to the center of the detector and the beam transverse shape, the fraction of charged particles 
crossing the chamber centered at (𝑋𝑋𝑖𝑖,𝑖𝑖,𝑌𝑌𝑖𝑖,𝑖𝑖) and the corresponding collected charge is precisely 
determined. This was done by randomly generating a sufficiently large number of tracks. The study has 
been repeated for different positions of the beam axis to evaluate the fraction of charge collected by each 
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FIG. 1. Sketch of the Monte Carlo 
simulation. The red circle represents the 
FWHM of the beam. Only four central 
chambers of MatriXX are shown. 
reconstruct the beam position and width using Eq. 1 and 2 and compared to the generated quantities. The 
systematic differences were tabulated to be used for later correction. 
The measurements performed with MatriXX were compared to the measurements using the CNAO QA 
standard procedures. At CNAO, QA measurements19 are currently done by using GAFCHROMIC® EBT film 
and a PTW Farmer® Ionization Chamber. GAFCHROMIC® EBT films, used to probe the field homogeneity, 
the beam FWHMs, and spot positions, are scanned using EPSON® scanner E1680-PRO (Epson America, Inc.). 
 
Measurements and Results 
The aim of this work is to explore whether ionization chamber arrays, specifically the MatriXX 2D detector, 
can be used for part of the QA procedure in CPT environment. For both carbon ion and proton beams we 
focused on three QA procedures: beam position measurement, beam width determination, and field dose 
uniformity. 
MatriXX was placed perpendicular to the beam at the isocenter position by aligning the external reference 
marks of the chamber to the laser alignment system of the treatment room. The beam impinged on 
MatriXX after crossing the vacuum window and, with a good approximation, the ionization chambers were 
probing the plateau of the depth dose curve. Thus, the beam energy is expected to have little impact on the 
measurements described above. We chose arbitrarily a beam energy equal to 221.45 MeV/u for carbon ion 
and 131.44 MeV for proton beams.  
When a uniform field was required, the scanning beam was steered across the detector in steps of 2 mm 
and 3 mm for carbon and proton beams respectively. These figures correspond to typical values used in 
patient treatments and ensure field homogeneity at the level of 1% or better. 
 
Beam position measurement accuracy 
The purpose of this measurement was to evaluate the accuracy of the MatriXX detector in measuring the 
position of a delivered spot. For this purpose the CNAO dose delivery system (DDS) was required to deliver 
a 7×7 grid of spots with a spacing of 26 mm for carbon and 30 mm for proton beams. The number of 
particles per spot was fixed to 3×107 carbon ions and 3×108 protons, and the total number of particles in a 
spot was typically reached in one single spill. The grid was obtained by a sequence of vertical sweeps of the 
beam where the current of the horizontal deflection magnet of the DDS was kept constant. The 
reconstructed spot positions of each vertical sweep were fitted to a straight line and the deviations were 
FIG. 2. a) Measured grid spot positions with the carbon ion beam. Blue points are the measurements and lines are 
added to indicate the spot sequence; b) blowup of the central column. The red line is the result of the fit. 
(a) (b) 
used to estimate the position resolution.  The rms was found to be as small as 13 µm, with a maximum 
deviation of 30 µm for protons, but substantially larger for carbon ions, 220 µm with a maximum deviation 
of 480 µm. This is due to the comparatively large pitch of the MatriXX grid with respect to the smaller beam 
FWHM of the carbon ion beam. For the carbon beam, Figure 2.a shows the pattern of the measured spot 
positions while Figure 2.b shows a blowup of the central column and the result of the fit. The full swing of 
the measurements is well contained within 480 µm. 
We remark that the beam position deviations from the straight line accounts only for the statistical 
contribution to the measurement errors. There could be an additional systematic effect, common to all the 
spots in the same column, related to the fixed relative horizontal position of the beam spots with respect to 
the column of chambers. To explore this contribution we repeated the same spot delivery after a small 
rotation of MatriXX detector about the beam axis. Repeating the vertical scan the spots would now be 
located at different relative positions between adjacent columns of chambers. 
For each of the two beam species, the 7 groups of 7 spots were fitted to straight lines imposing the same 
slope. The deviations of the measured positions from the fitted line have a magnitude similar to the 
untilted chamber for protons (rms of 14 µm with a maximum deviation of 25 µm), but appear to be larger 
for carbon ions (rms of 580 µm with a maximum deviation of 1.2 mm). This results suggest that the 
accuracy of the beam position measurements strongly depends on the beam FWHM, being very good for 
beams width FWHM of 10 mm or more, and barely within the required position accuracy (±1 mm) for 
narrower beams of FWHM ≈ 6 mm. The histograms of the deviations are shown in figure 3.a for carbon ion 
and in figure 3.b for proton beams. 
We investigated the systematic effects in the beam position measurement originated by the MatriXX 
chamber spacing and their dependence on the beam FWHM. For this purpose, the simulation described in 
the previous section was performed by generating a large number of beam positions (≈ 50×50) uniformly 
covering the square area defined by 4 adjacent chambers (see Fig. 1). The beam shape was described by a 
two dimensional Gaussian distribution with equal widths in both directions. From the simulation, the shifts 
along the 𝑋𝑋 and 𝑌𝑌 directions, 𝑆𝑆𝑥𝑥(𝑋𝑋,𝑌𝑌,𝑊𝑊) and 𝑆𝑆𝑦𝑦(𝑋𝑋,𝑌𝑌,𝑊𝑊), between the reconstructed beam position and 
the generated one were recorded, for later use, as a function of 𝑋𝑋, 𝑌𝑌 and the beam FWHM 𝑊𝑊.  The 
FIG. 3. Histogram of deviations from a straight line for a) carbon ion (FWHM = 6 mm) and b) proton beams (FWHM = 10 mm) 
a 
b 
correction 𝑆𝑆𝑥𝑥 (𝑆𝑆𝑦𝑦) is found to depend on only on 𝑋𝑋 (respectively 𝑌𝑌). In addition, being the problem 
completely symmetrical in 𝑋𝑋 and 𝑌𝑌, we can write 𝑆𝑆𝑥𝑥(𝑋𝑋,𝑊𝑊) = 𝑆𝑆𝑦𝑦(𝑌𝑌,𝑊𝑊) = 𝑆𝑆 for 𝑋𝑋 = 𝑌𝑌. As expected, 𝑆𝑆 
strongly depend on 𝑊𝑊. The 𝑆𝑆 values are plotted for carbon ions, with 𝑊𝑊 = 6 mm, in Fig. 4.a, and for 
protons, with 𝑊𝑊 = 10 mm, in Fig. 4.b, as a function of the 𝑋𝑋 position of the beam relative to the center of 
MatriXX (see Fig. 1). For a FWHM of 10 mm the shift is well confined within ±50 µm, while the smaller beam 
size induces a correction up to ±1 mm. 
To improve the precision of the beam position measurement, we applied the shift corrections with the 
following equations: 
𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐
𝑐𝑐𝑐𝑐𝑟𝑟𝑟𝑟 = 𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐 + 𝑆𝑆�𝑋𝑋𝑐𝑐𝑐𝑐𝑐𝑐,𝑊𝑊� ,    𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑟𝑟𝑟𝑟 = 𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐 + 𝑆𝑆�𝑌𝑌𝑐𝑐𝑐𝑐𝑐𝑐,𝑊𝑊�                 (3) 
To apply this correction, we assumed that the value of 𝑊𝑊 is known from independent measurements. In 
Figure 5, we show the distributions of the deviations of the positions from the fitted lines for carbon ions 
and protons after the shift corrections of Eq. 3 have been applied. As expected, for carbon ion beams (Fig. 
5.a) the improvement is noticeable, reducing the rms from 580 to 230 µm. For protons (Fig. 5.b), the 
improvement is almost negligible, reducing the rms from 14 µm to 8 µm. 
The effect of the corrections is particularly impressive when applied to a large sequence of 6 mm-FWHM 
beam spots for the delivery of a (6×6 cm2) uniform square field with steps of 2 mm along 𝑋𝑋 and 𝑌𝑌 
directions. The scan was done by moving the beam vertically and, once swept a vertical line, by moving it 
horizontally by 2 mm. A spill could cover on average three vertical spots, thus the center of gravity gives the 
average positions of the three spots. In Figure 6.a we show the positions, as reconstructed with MatriXX 
with Eq. 1, and in Figure 6.b we show the same sequence after the corrections have been applied. The 
positions prior corrections are not as regular as the DDS provides. Once the positions have been corrected 











FIG. 4. Systematic deviations of the reconstructed from the generated beam centers as a function of the beam position. The 
beam position origin is set in the center of MatriXX. Being a periodic function of the position, a single cycle corresponding 
to the distance between the two central chambers is shown: a) is for carbon ion beam and b) is for proton beam 
FIG. 5. Distribution of deviation from a straight line after corrections have been 
applied: a) is for carbon ion (FWHM = 6 mm) and b) is for proton beams (FWHM = 10 mm) 
(a) (b) 
Beam width determination 
The measurement of the beam width along 𝑋𝑋 and 𝑌𝑌 coordinates is a crucial part of the daily QA as a too 
narrow or too wide beam can affect the dose uniformity or the lateral dose fall-off. The FWHM of the beam 
transverse distribution is commonly used to describe the beam transverse size. Typically, a tolerance of ±1 
mm is set to this quantity. 
MatriXX and GAFCHROMIC® EBT3-1417 film (MediTron, Switzerland, Frauenfeld) were simultaneously 
exposed to a 3×3 grid of spots, 10 cm apart, 3×107 carbon ions each (see Fig. 7.); being smaller the 
transverse dimension of the beam tends to generate a larger systematic error. A typical horizontal 
projection of the gray levels of a spot measured with the film is shown in Fig. 8. 
While the vertical scale is arbitrary, the horizontal scale gives the position in mm. The average FWHM for 
carbon ion beams as measured from the film analysis are 6.5 ± 0.1 mm along X and 5.4 ± 0.1 mm along Y. 
The FWHM measured with MatriXX were found to be: XFWHM = (7.3 ± 0.2) mm, YFWHM = (5.1 ± 0.4) mm, 
where Eq. 2 was used and the errors have been derived from the fluctuations of the 3×3 measurements. A 
similar approach of the one pursued to reduce the systematic errors for the position measurement was 
then applied. With the Monte Carlo simulation a correction to the measured width, dependent on the 
beam position, was applied to the raw measurements. After correction, the FWHM resulted to be (6.3 ± 
0.1) mm along X and (5.7 ± 0.5) along Y. The agreement between film and MatriXX is within 0.3 mm, which 
is well below the ±1 mm limit required. 
 
FIG. 6. Sequence of spots to deliver a square field of 6 cm × 6 cm. Figures show the positions 
reconstructed a) before and b) after corrections, explained in the text, have been applied. 
(a) (b) 
FIG. 7. Picture of the set-up, right 
after irradiation: beam spots are 
visible on the strips of Gafchromic 
films, which have been taped to the 
MatriXX surface. 
Field dose uniformity  
At CNAO, the dose uniformity level in a square field is part of the daily QA checks. It is currently done by 
irradiating a Gafchromic film with a square uniform field and by determining the dose flatness along the 
horizontal and vertical directions.  We used MatriXX to perform the same check.   
First, we investigated the uniformity of the gain of the MatriXX by delivering a 5×5 spot grid with 1.5×1010 
protons/spot in steps of 35 mm, thus covering an area of 14×14 cm2 where spots are fully contained in the 
active area of the detector. The DDS of CNAO is designed and calibrated to deliver particles with high 
precision, at the per mille level.28 Therefore only negligible deviations in number of particles between 
different spots are expected. From the number of counts, integrated over all the MatriXX chambers for 
each spot, a relative standard deviation between spots equal to 0.36% and a maximum deviation of ±0.8% 
is observed, showing a good uniformity of the detector.   
Later, MatriXX was exposed to a uniform 6×6 cm2 square field with both carbon ion and proton beams. In 
the case of carbon ion beams, the dose profiles were simultaneously measured by positioning a Gafchromic 
film on the front surface of MatriXX. The profiles along X (Y) were obtained by considering a single row 
(column) of chambers of MatriXX positioned at the center of the field. For comparison, the sum of 20 rows 
(columns) of pixels of the film image located at the same position was considered. The results along X are 
shown in Figure 9. 
The flatness was defined as 
𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓𝑓 = 𝐼𝐼𝑚𝑚𝑚𝑚𝑥𝑥 − 𝐼𝐼𝑚𝑚𝑖𝑖𝑚𝑚
𝐼𝐼𝑚𝑚𝑚𝑚𝑥𝑥 + 𝐼𝐼𝑚𝑚𝑖𝑖𝑚𝑚 × 100                 (4) 
where 𝐼𝐼𝑚𝑚𝑚𝑚𝑥𝑥 and 𝐼𝐼𝑚𝑚𝑖𝑖𝑚𝑚 are the maximum and minimum values found in the dose plateau. This condition was 
ensured by considering only the measurements covering 80% of the central region of the plateau. The 
FIG. 9. Dose profiles of a 6×6 cm2 square uniform field from a) film and b) MatriXX 
measurements. The irradiation has been obtained with a carbon ion beam. 
(a) (b) 
FIG. 8. a) Horizontal and b) vertical projection of the gray levels of a spot measured with the film. 
(b) (a) 
plateau is defined as the region where measurements are above 90% of the maximum. The tolerance of 
flatness used for the QA is set to ±3%. The measured carbon ion beam field flatness with MatriXX was 
found to be better than 2% in both directions, in agreement with the film measurements, 2.6% flatness in X 
and 2.3% flatness in Y. Similar results were obtained with protons, where the measured flatness was found 
to be 1.7% in X and 1.3% in Y directions. 
 
Discussion 
Quality assurance for CPT is a lengthy procedure that, in many centers, relies both on film measurement 
and on pinpoint ionization chambers. Many efforts have been devoted to reducing the length of the 
procedure without affecting the sensitivity. 
Several years ago our group developed a 2D ionization chamber, commercially known as MatriXX, and 
more recently, designed and implemented the Dose Delivery System in use at CNAO. It is then being natural 
the match of both expertise to provide a feasibility study for the use of MatriXX in the QA of CPT. Indeed 
the same type of detector was investigated at MD Anderson with protons whilst, in this paper, we focus 
mainly on the carbon and in parallel we verify the results for proton beams. 
In this context we show that precise beam position and fast 2D dose distribution information can be 
determined very quickly using the MatriXX detector. With a chamber pitch of 7.619 mm, MatriXX has a 
sampling grid that is much larger than a film. However it is well known from the literature that by 
measuring the beam tails in the transverse plane one can accurately derive the beam central position 
provided that the beam width is known. We remark that prior QA, or before a patient treatment for that 
matter, among the several settings of the machine, the beam width is one of the key parameters to be 
chosen, and this value is the one we need to know to apply reliably the corrections.  
For this work we evaluated the corrections with a simple and quick simulation and the results were stored 
in a file as a function of the beam widths allowed by machine, both for carbon ion and proton beams. The 
pre-computed corrections were then applied for the measurement of both the beam position and width. 
Once the corrections have been applied the precision of position and width is at the sub-millimeter level. In 
summary with this method one can derive online the beam position and verify the beam width. 
For what concerns the verification of the flatness one has to differentiate between a local irregularity and 
global deviation. In the former, if the dimension of the irregular delivery area is smaller than the pitch then 
MatriXX can fail the detection. On the other hand a global deviation can be detected at the level of 2% or 
less. In fact, the results show that MatriXX is quick and accurate enough to be used to determine the dose 
flatness of the scanned ion beam.  
The performance of the 2D MatriXX detector in accurately and quickly measuring the beam position, beam 
size, dose field uniformity and flatness shows that this 2D detector is a well suited device for quality 
assurance checks of spot scanning ion beam therapy. 
 
Conclusions 
From this study we conclude that a 2D detector (in this paper we investigated the case of MatriXX) can 
replace films in part of the QA procedures in CPT centers. While films require a lengthy procedure for 
preparing, scanning, and offline analysis and a single ionization chamber requires repetitive beam 
deliveries, a 2D detector can be used to measure many parameters of a scanned ion beam quickly and 
precisely. The results suggest that the QA would benefit from a new protocol where the MatriXX detector is 
added to the existing systems. 
 
1 ESTRO (1995) EUROPEAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY, “Quality assurance in radiotherapy,” 
Radiother. Oncol. 35, 61–73 
2 AAPM (1984) AMERICAN ASSOCIATION OF PHYSICISTS IN MEDICINE, “Physical Aspects of Quality Assurance in Radiation Therapy,” 
AAPM Task Group 24 Report, AAPM, New York 
3 C-M Charlie Ma, Tony Lomax, “Proton and Carbon Ion Therapy,” October 9, 2012 by CRC Press 
4 D. Nichiporov, K. Solberg, W. Hsi, M. Wolanski, A. Mascia, J. Farr, and A. Schreuder, “Multichannel detectors for profile 
measurements in clinical proton fields,” Med. Phys. 34, 2683–2690 (2007) 
5 S. Vatnitsky, “Radiochromatic film dosimetry for clinical proton beams,” Appl. Radiat. Isot. 48, 643–651 (1977) 
6 D. Nichiporov, V. Kostjuchenko, J. M. Puhl, D. L. Bensen, M. F. Desrosiers, C. E. Dick, W. L. McLaughlin, T. Kojima, B. M. Coursey, 
and S. Zink, “Investigation of applicability of alanine and radiochochromic detectors to dosimetry of proton clinical beams,” Appl. 
Radiat. Isot. 46, 1355–1362 (1995) 
7 A. M. Gueli, R. De Vincolis, A. Kacperek, and S. O. Troja, “An approach to 3D dose mapping using Gafchromic film,” Radiat. Prot. 
Dosim. 115, 616–622 (2005) 
8 S. O. Troja, E. Egger, P. Francescon, A. M. Gueli, A. Kacperek, M. Coco, R. Musmeci, and A. Pedalino, “2D and 3D dose distribution 
determination in proton beam radiotherapy with GafChromic film detectors,” Technol. Health Care8, 155–164 (2000) 
9 I. Daftari, C. Castenadas, P. L. Petti, R. P. Singh, and L. J. Verhey, “An application of GafChromic MD-55 film for 67.5 MeV clinical 
proton beam dosimetry,” Phys. Med. Biol. 44, 2735–2745 (1999) 
10 Y. Hara, T. Furukawa, K. Mizushima, E. Takeshita, T. Shirai, K. Noda, “Application of radiochromic film for quality assurance in the 
heavy-ion beam scanning irradiation system at HIMAC,” Nuclear Instruments and Methods in Physics Research, B 331, 253–256 
(2014) 
11 J. Herzen, M. Todorovic, F. Cremers, V. Platz, D. Albers, A. Bartels, and R. Schmidt, “Dosimetric evaluation of a 2D pixel ionization 
chamber for implementation in clinical routine,” Phys. Med. Biol. 52, 1197–1208 (2007) 
12 B. Poppe, A. Blechschmidt, A. Djouguela, R. Kollhoff, A. Rubach, K. C. Willborn, and D. Harder, “Two-dimensional ionization 
chamber arrays for IMRT plan verification,” Med. Phys. 33, 1005–1015 (2006) 
13 M. Stasi, S. Giordanengo, R. Cirio, A. Boriano, F. Bourhaleb, I. Cornelius, M. Donetti, E. Garelli, I. Gomola, F. Marchetto, M. Porzio, 
C. J. Sanz Freire, A. Sardo, and C. Peroni, “D-IMRT verification with a 2D pixel ionization chamber: Dosimetric and clinical results in 
head and neck cancer,” Phys. Med. Biol. 50, 4681–4694 (2005) 
14 B. Arjomandy, N. Sahoo, X. Ding, and M. Gillin, “Use of a two-dimensional ionization chamber array for proton therapy beam 
quality assurance,” Med. Phys. 35, 3889–3894 (2008) 
15 B. Arjomandy, N. Sahoo, G. Ciangaru, R. Zhu, “Verification of patient-specific dose distributions in proton therapy using a 
commercial two-dimensional ion chamber array,” Med. Phys. 37, 5831–5837 (2010) 
16 B. Arjomandy, M. Gillin, X. R. Zhu, N. Sahoo, G. Ciangaru, M. Bues, and F. Poenisch, “A 2D ion chamber array detector as a QA 
device for spot scanning proton beams,” Med. Phys. 35, 2779–2779 _2008_. 
17 N. Sahoo, X. R. Zhu, B. Arjomandy, G. Ciangaru, X. Ding, and M. Gillin, “Feasibility study of a set of quality assurance checks for 
spot scanning proton therapy beams by using 2-D ion chamber array,” Int. J. Radiat.Oncol., Biol., Phys. 75, S698–S699 (2009). 
18 S. Rossi, “The status of CNAO,” Eur. Phys. J. Plus. 126: 78 (2011) 
19 A. Mirandola, S. Molinelli, G. Vilches Freixas, A. Mairani, E. Gallio, D. Panizza, S. Russo, M. Ciocca, M. Donetti, G. Magro, S. 
Giordanengo, and R. Orecchia, “Dosimetric commissioning and quality assurance of scanned ion beams at the Italian National 
Center for Oncological Hadrontherapy,” Med. Phys. 42, 5287–5300 (2015) 
20 S. Rossi, “Developments in proton and light-ion therapy,” In: Proceedings of the 10th EPAC. Edinburgh: 3631–35 (2006) 
21 M. Pullia, “The National Center For Oncological Hadrontherapy In Italy (CNAO): Design and Status,” AccApp 2013 (11th 
international topical meeting on nuclear applications of accelerators), Bruges, Belgium 
22 IBA Dosimetry, Radiotherapy; 
http://www.iba-dosimetry.com/complete-solutions/radiotherapy/imrt-igrt-rotational-qa/matrixxes 
23 S. Amerio, A. Boriano, F. Bourhaleb, R. Cirio, M. Donetti, A. Fidanzio, E. Garelli, S. Giordanengo, E. Madon, F. Marchetto, U. 
Nastasi, C. Peroni, A. Piermattei, C. J. Sanz Freire, A. Sardo, and E. Trevisiol, “Dosimetric characterization of a large area pixel-
segmented ionization chamber,” Phys. Med. Biol. 31, 414–420 (2004) 
24 Liyong Lin, Minglei Kang, Timothy D. Solberg, Thierry Mertens, Christian Baumer, Christopher G. Ainsley, James E. McDonough, 
“Use of a novel two-dimensional ionization chamber array for pencil beam scanning proton therapy beam quality assurance,” 
Journal of Applied Clinical Medical Physics, Vol. 16 , No. 3 (2015) 
25 S. Alashrah, S. Kandaiya, S. Y. Yong, and S. K. Cheng, “Characterization of a 2D ionization chamber array for IMRT plan 
verification,” Nuclear Instruments and Methods in Physics Research, A 619, 181–185 (2010) 
26 National Instruments, http://www.ni.com/labview/ 
27 IBA Dosimetry, Radiotherapy; 
http://www.iba-dosimetry.com/complete-solutions/radiotherapy/imrt-igrt-rotational-qa/omnipro-i-mrt 
28 S. Giordanengo, M. A. Garella, F. Marchetto, F. Bourhaleb, M. Ciocca, A. Mirandola, V. Monaco, M. A. 
Hosseini, C. Peroni, R. Sacchi, R. Cirio, and M. Donetti, “The CNAO dose delivery system for modulated scanning ion beam 
radiotherapy,” Med. Phys. 42, 263 (2015) 
